Table 2. .
The Most-Significant Gene Sets and Pathways Identified by a Preranked Module of the GSEA Algorithm for Two GWA Studies of PD and One GWA Study of AMD
Rank of Most Significant |
||||||
Study and Gene Set or Pathways | Set Size | SNP | Gene | Nominal P | FDR | FWER P |
Fung et al.12 stage 1 association study of PD: | ||||||
Glutamate receptor activity | 39 | 109 | 77 | <.0001 | .003 | .003 |
O-glycan biosynthesis | 23 | 155 | 114 | <.0001 | .002 | .003 |
Ligand-gated ion channel activity | 97 | 207 | 153 | <.0001 | .001 | .004 |
Transmembrane receptor protein phosphatase activity | 20 | 147 | 106 | <.0001 | .004 | .015 |
GABA receptor activity | 23 | 109 | 77 | <.0001 | .010 | .048 |
Maraganore et al.13 tier 1 association study of PD: | ||||||
Axon guidance | 56 | 44 | 31 | <.0001 | .005 | .006 |
CNS development | 130 | 118 | 86 | <.0001 | .034 | .068 |
Glutamate receptor activity | 35 | 34 | 23 | .0007 | .069 | .189 |
Klein et al.25 association study of AMD: | ||||||
CFH-related pathway | 4 | 1 | 1 | <.0001 | .004 | .004 |
ABC transporters | 42 | 157 | 111 | <.0001 | .046 | .088 |
Skeletal muscle fiber development | 25 | 75 | 51 | <.0001 | .065 | .181 |